NAS10030,482+2.83%S&P7,765+1.49%GOLD$4,362−0.51%BTC$85,955−0.75%VIX14.66−1.41%live tape · as of 15:00 UTC
The Screen · Technology · Semiconductors
Intel
INTC · a US exchange · USD · Market cap $612.1B · 85,100 employees
Intel Corporation designs, develops, manufactures, markets, sells, and services computing and related end products and services in the United States, Ireland, Israel, and internationally.
Positioning political selling, disclosed 2026-08-03
Options no verdict drawn today, left as found
Ethical passes the values gate
Price121.78 USD
Fair value64.63
Ethical score83.2/100
RatingAVOID
Our investment reviews on this name
2026-08-24Read Distribution92.13+32.2% to today
2026-07-03Read Markup99.17+22.8% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Intel holds its Markup at $121.78. The statistical read favours the sellers, held for 21 days.
As held on the ledger · 2026-09-21
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 21 days
Price at the screen
$121.78
Valuation
N/A trailing · 59.63 forward price to earnings
Values screen
PASS· score 83.2
Beta
2.23
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
22.03%
Below 33%
Interest-bearing debt is just 22.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
4.03%
Below 33%
Cash held in interest-bearing accounts and securities is 4.0% of assets, under the one-third limit.
Pass
Receivables
8.56%
Below 49%
Money owed to the company is 8.6% of assets, under the 49% limit.
Pass
Revenue purity
1.91%
Below 5%
Only 1.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience Overlay
Conscience flag · BDS Movement
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited by BDS movement for operating major chip fabrication and R&D facilities in Israel, representing one of the country's largest private employers. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades above our $64.63 fair value estimate, weak competitive moat, 25.40% revenue growth.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 46.9% above the base estimate.
Third-party analyst targets: 41 covering, consensus Buy. The average target sits −8% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Chip Giant's Numbers Don't Match the Price
Imagine every desktop PC, laptop, and server humming with the sound of Intel processors - a familiar tune in the tech symphony. Despite its dominance, Intel's current market price of $92.13 stands in stark contrast to our fair value estimate of $63.62, suggesting a discount of 31%. This misalignment is why it stands out to us as an avoid. While Intel boasts a robust 25% revenue growth, it's operating in a cyclical industry where these figures might be hiding a peak earnings trap.
The numbers further reveal a worrying -20% profit margin and an -11% return on equity, painting a picture of a company struggling under its own weight. Its 'weak' moat suggests that Intel's competitive advantages are being eroded, while the consensus hold rating from 41 analysts and a median target of $110 is notably higher than our valuation.
Risks are high in this play, given the cyclical nature of the semiconductor industry and Intel's financials. The forward P/E of 45.2x is another red flag, hinting at overvaluation, even as the ethical screen gives Intel a pass. Investors should tread carefully, as the numbers suggest that Intel may not be the resilient investment it once was. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
INTC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88.
2026-07-23Markup$95.04+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Markup$95.04+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markup$95.04+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Markup$95.04+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-19Markup$95.04-4.2%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markup$99.17+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-17Markup$99.17+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-16Markup$99.17+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 159% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 385%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (42 analysts) rates it hold, with a mean price target of $88. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-03Markup$99.17+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
